1-20 of 47
Stephanie Guidez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma

Clinical Trials & Observations
Gilles Crochet, Gloria Iacoboni, Audrey Couturier, Emmanuel Bachy, Josu Iraola-Truchuelo, Thomas Gastinne, Guillaume Cartron, Tom Fradon, Bastien Lesne, Mi Kwon, Romain Gounot, Nuria Martínez-Cibrian, Cristina Castilla-Llorente, Pau Abrisqueta, Manuel Guerreiro, Clémentine Sarkozy, Jose María Aspa-Cilleruelo, Vincent Camus, Stéphanie Guidez, Adrien Chauchet, Eric Deconinck, Krimo Bouabdallah, Francesc Bosch, Pere Barba, Franck Morschhauser, Roch Houot
Journal: Blood
Blood (2024) 144 (3): 334–338.
https://doi.org/10.1182/blood.2024024526
Published: 2024
Includes: Supplemental data
Journal Articles

High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia

Clinical Trials & Observations
Eric Durot, Damien Roos-Weil, Adrien Chauchet, Justine Decroocq, Roberta Di Blasi, Thomas Gastinne, Hedi Bensaber, Morgane Cheminant, Caroline Jacquet, Stéphanie Guidez, François-Xavier Gros, Emmanuel Bachy, Arthur Coste, Pascale Cony-Makhoul, Steven P. Treon, Alain Delmer, Ran Reshef, Steven Le Gouill, Jorge J. Castillo, Roch Houot
Journal: Blood
Blood (2024) 143 (26): 2804–2807.
https://doi.org/10.1182/blood.2024024452
Published: 2024
Includes: Supplemental data
Journal Articles

The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients

Clinical Trials & Observations
Hervé Ghesquières, Daphné Krzisch, Emmanuelle Nicolas-Virelizier, Salim Kanoun, Anne Claire Gac, Stéphanie Guidez, Mohamed Touati, Kamel Laribi, Franck Morschhauser, Christophe Bonnet, Agathe Waultier-Rascalou, Frédérique Orsini-Piocelle, Marc André, Marguerite Fournier, Fabienne Morand, Alina Berriolo-Riedinger, Barbara Burroni, Diane Damotte, Alexandra Traverse-Glehen, Philippe Quittet, Olivier Casasnovas
Journal: Blood
Blood (2024) 143 (11): 983–995.
https://doi.org/10.1182/blood.2023021564
Published: 2024
Includes: Supplemental data
Journal Articles

Tazemetostat in Combination with R-CHOP in Patients with High-Risk, Frontline Follicular Lymphoma (Epi-RCHOP): A Phase II Study from the Lysa

Loic Ysebaert, Francois Lemonnier, Gabriel Brisou, Olivier Casasnovas, Gian Matteo Pica, Emmanuel Bachy, Ludovic Fouillet, Julie Abraham, Stephanie Guidez, Marc André, Guillaume Cartron, Romain Guieze, Sylvain Carras, Benoit Tessoulin, Roch Houot, Bohrane Slama, Christophe Bonnet, Luc-Matthieu Fornecker, Marie-Helene Delfau, Clementine Sarkozy, Camille Laurent, Vincent Ribrag, Franck Morschhauser
Journal: Blood
Blood (2023) 142 (Supplement 1): 297.
https://doi.org/10.1182/blood-2023-185057
Published: 2023
Journal Articles

Combining PET/CT and Ctdna Assessments at 6 Months from Induction Treatment Better Predicts Outcome in Previously Untreated Patients with Follicular Lymphoma: A Relevance Ancillary Lysa Study

Alexis Claudel, Anne Ségolène Cottereau, Emmanuel Bachy, Pierre Feugier, Rene-Olivier Casasnovas, Corinne Haioun, Herve Tilly, Nicolas Daguindau, Guillaume Cartron, Emmanuelle Nicolas Virelizier, Pauline Brice, Benoit Tessoulin, Christophe Fruchart, Sylvie Glaisner, Alain Jacques Delmer, Emmanuel Fleck, Gian Matteo Pica, Hacene Zerazhi, Stephanie Guidez, Morgane Cheminant, Luc Xerri, Laetitia Vercellino, Loïc Chartier, Lucie Gomes, Pierre-Julien Viailly, Marie-Helene Delfau, Franck Morschhauser
Journal: Blood
Blood (2023) 142 (Supplement 1): 170.
https://doi.org/10.1182/blood-2023-178030
Published: 2023
Journal Articles

Real World Data of Axicabtagene Ciloleucel As Second Line Therapy for Patients with Large B Cell Lymphoma: First Results of a Lysa Study from the French Descar-T Registry

Gabriel Brisou, Guillaume Cartron, Emmanuel Bachy, Catherine Thieblemont, Cristina Castilla-Llorente, Fabien Le Bras, François-Xavier Gros, Michael Loschi, Roch Houot, Remy Dulery, Fabrice Jardin, Magalie Joris, Choquet Sylvain, Franck Morschhauser, Stephanie Guidez, Olivier Hermine, Laurianne Drieu La Rochelle, Sylvain Carras, Blandine Guffroy, Pierre Bories, Rene-Olivier Casasnovas, Julie Abraham, Steven Le Gouill, Pascale Cony-Makhoul, Elodie Gat, Benoit Tessoulin
Journal: Blood
Blood (2023) 142 (Supplement 1): 5138.
https://doi.org/10.1182/blood-2023-180241
Published: 2023
Journal Articles

Results of a Second, Prespecified Analysis of the Phase 2 Study ELM-2 Confirm High Rates of Durable Complete Response with Odronextamab in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) with Extended Follow-up

Jose. C. Villasboas, Tae Min Kim, Michal Taszner, Silvana Novelli, Seok-Goo Cho, Michele Merli, Ana Jimenez Ubieto, Benoit Tessoulin, Michelle Poon, Jan Walewski, Shuhua Yi, Yuqin Song, Geoffrey Chong, Stefano Luminari, Emmanuel Bachy, Stephanie Guidez, Aranzazu Alonso, Deepa Jagadeesh, Wei Zhang, Laura Magnano, Elżbieta Iskierka-Jażdżewska, Monica Tani, Jessica Cai, Amulya Uppala, Saleem Shariff, Lei Chi, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, David Tucker
Journal: Blood
Blood (2023) 142 (Supplement 1): 3041.
https://doi.org/10.1182/blood-2023-181650
Published: 2023
Journal Articles

Maintenance of Moderate to High Levels of Functioning and Quality of Life with Odronextamab Monotherapy in Patients with Relapsed or Refractory Follicular Lymphoma

Benoit Tessoulin, Seok-Goo Cho, Michal Taszner, Tae Min Kim, Silvana Novelli, Jose C. Villasboas, Michele Merli, Ana Jimenez Ubieto, Michelle Poon, David Tucker, Jan Walewski, Shuhua Yi, Yuqin Song, Geoffrey Chong, Emmanuel Bachy, Stephanie Guidez, Aranzazu Alonso, Deepa Jagadeesh, Wei Zhang, Laura Magnano, Elzbieta Iskierka-Jazdzewska, Monica Tani, Jessica Cai, Cristina Ivanescu, Matthew Reaney, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, James Harnett, Lei Chi, Stefano Luminari
Journal: Blood
Blood (2023) 142 (Supplement 1): 669.
https://doi.org/10.1182/blood-2023-181942
Published: 2023
Journal Articles

Results of the Phase II of Epirchop Study, Evaluating the Efficacy of Tazemetostat in Combination with R-CHOP in Elderly Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL): A Lysa Study

Clementine Sarkozy, Thierry Jo Molina, Roch Houot, Sydney Dubois, Gian Matteo Pica, Philippe Ruminy, Charles Herbaux, Thomas Gastinne, Corinne Haioun, Stephanie Guidez, Christophe Bonnet, Marc Andre, Liana Vereseza, Choquet Sylvain, Loic Ysebaert, Emmanuel Bachy, Fabrice Jardin, Franck Morschhauser, Vincent Ribrag
Journal: Blood
Blood (2023) 142 (Supplement 1): 853.
https://doi.org/10.1182/blood-2023-174607
Published: 2023
Journal Articles

CD19-Targeting CAR T-Cell Therapy in Transformed Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: A Descar-T and US Collaborative Study

Eric Durot, Damien Roos-Weil, Adrien Chauchet, Justine Decroocq, Roberta Di Blasi, Thomas Gastinne, Hedi Bensader, Morgane Cheminant, Caroline Jacquet, Stephanie Guidez, François-Xavier Gros, Emmanuel Bachy, Pascale Cony-Makhoul, Steven P Treon, Alain Jacques Delmer, Ran Reshef, Steven Le Gouill, Jorge J. Castillo, Roch Houot
Journal: Blood
Blood (2023) 142 (Supplement 1): 616.
https://doi.org/10.1182/blood-2023-173988
Published: 2023
Journal Articles

Efficacy of Chimeric Antigen Receptor T-Cell Therapy Is Not Impaired By Previous Bispecific Antibody Treatment in Patients with Large B-Cell Lymphoma

Gloria Iacoboni, Gilles Crochet, Audrey Couturier, Emmanuel Bachy, Josu Iraola, Thomas Gastinne, Charles Herbaux, Tom Fradon, Mi Kwon, Romain Gounot, Nuria Martinez-Cibrian, Cristina Castilla-Llorente, Manuel Guerreiro, Clementine Sarkozy, Jose Aspa-Cilleruelo, Vincent Camus, Stephanie Guidez, Adrien Chauchet, Eric Deconinck, Krimo Bouabdallah, Pere Barba, Roch Houot, Franck Morschhauser
Journal: Blood
Blood (2023) 142 (Supplement 1): 228.
https://doi.org/10.1182/blood-2023-185035
Published: 2023
Journal Articles

Synthetic Control Arm from Clinical Trials and Real-World Data from Lysa Group for Untreated Diffuse Large B Cell Lymphoma Patients Aged over 80 Years: A Bona Fide S trategy for Innovative Clinical Trials

Valentin Letailleur, Isabelle Chaillol, Fanny Cherblanc, Herve Ghesquieres, Frederic Peyrade, Fabrice Jardin, Stephanie Guidez, Fontanet Delices Bijou, Pierre Sesques, Cédric Rossi, Luc Matthieu Fornecker, Ludovic Fouillet, Sylvain Carras, Benoit Tessoulin
Journal: Blood
Blood (2023) 142 (Supplement 1): 72.
https://doi.org/10.1182/blood-2023-177708
Published: 2023
Journal Articles

Mixture Model to Predict the Cumulative Incidence of Relapses in Follicular Lymphoma : Need for Longer Follow-up or Alternative Outcomes

Stephanie Guidez, Sylvie Glaisner, Eric Van Den Neste, Emmanuel Gyan, Zora Marjanovic, Luc-Matthieu Fornecker, Eric Deconinck, Michel Fabbro, Veronique Dorvaux, Daniela Robu, Hisayuki Yokoyama, Nathalie A. Johnson, Matthew C. Cheung, Sylvia Snauwaert, María Casanova, Yasuhito Terui, Go Yamamoto, Yuvraj Choudhary, Joseph Ronald Mace, Donald P. Quick, Franck Morschhauser, Yohann Foucher
Journal: Blood
Blood (2023) 142 (Supplement 1): 7401.
https://doi.org/10.1182/blood-2023-189296
Published: 2023
Journal Articles

Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Final Analysis of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"

Olivier Tournilhac, Solene Lecolant, Maya Hacini, Krimo Bouabdallah, Sebastien Bailly, Kamel Laribi, Thibaut Belmondo, Marie Maerevoet, Loic Ysebaert, Stéphanie Guidez, Steven Le Gouill, Christophe Bonnet, Marc Andre, Jehan Dupuis, Catherine Thieblemont, Emmanuel Bachy, Nicolas Daguindau, Franck Morschhauser, Sabine Tricot, Pierre Feugier, Anne Banos, Thierry Lamy, Adrien Chauchet, Emmanuel Gyan, Guillaume Cartron, Hassan Farhat, Vincent Camus, Bernard Drenou, Hacene Zerazhi, David Sibon, Emmanuelle Nicolas-Virelizier, Caroline Delette, Sylvia Snauwaert, Nicole Straetmans, Richard Delarue, Marie Parrens, Samuel Griolet, Philippe Gaulard, Marie-Helene Delfau-Larue, Laurence De Leval, Gandhi Laurent Damaj
Journal: Blood
Blood (2022) 140 (Supplement 1): 2302–2305.
https://doi.org/10.1182/blood-2022-165217
Published: 2022
Journal Articles

Real Life Analysis of Brentuximab Vedotin (BV) Use As Consolidation Therapy in Patients with Hodgkin's Lymphoma (HL) with High Risk of Relapse after Autologous Stem Cell Transplantation (ASCT). a Retrospective Analysis of the EBMT Lymphoma Working Party

Maria Carmen Martinez Munoz, Mariana Bastos-Oreiro, Ariane Boumendil, Hervé Finel, Ali Bazarbachi, Mohsen Alzahrani, Arpad Illes, Didier Blaise, Ioanna Sakellar, Carlos Solano, Alessandro Pulsoni, Tsila Zuckerman, Nadira Durakovic, Luca Castagna, Simona Sica, Stéphanie Guidez, Jean-Henri Bourhis, Ramón García-Sanz, Muhlis Cemm Ar, Aspasia Stamatoulas Bastard, Javier Briones, Saad Aktar, Ron Ram, Inmaculada Heras, Marie Thérèse Rubio, Mario Petrini, Mario Ojeda-Uribe, Bertram Glass, Anna Sureda
Journal: Blood
Blood (2022) 140 (Supplement 1): 6558–6560.
https://doi.org/10.1182/blood-2022-167644
Published: 2022
Journal Articles

Odronextamab in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Grade 1-3a: Results from a Prespecified Analysis of the Pivotal Phase II Study ELM-2

Tae Min Kim, Michal Taszner, Seok-Goo Cho, Silvana Novelli, Steven Le Gouill, Michelle Limei Poon, Jose C. Villasboas, Rebecca Champion, Emmanuel Bachy, Stéphanie Guidez, Aránzazu Alonso Alonso, Deepa Jagadeesh, Michele Merli, David Tucker, Jingxian Cai, Carolina Leite De Oliveira, Min Zhu, Aafia Chaudhry, Hesham Mohamed, Srikanth R. Ambati, Stefano Luminari
Journal: Blood
Blood (2022) 140 (Supplement 1): 2280–2282.
https://doi.org/10.1182/blood-2022-158404
Published: 2022
Journal Articles

CAR T-Cell Therapy Remain Effective in Patients with Relapse/Refractory B-Cell Non-Hodgkin Lymphoma after Bispecific Antibodies Exposure: Results of a Lysa Study Based on the Descar-T Registry

Gilles Crochet, Couturier Audrey, Emmanuel Bachy, Thomas Gastinne, Guillaume Cartron, Tom Fradon, Romain Gounot, Cristina Castilla-LLorente, Clementine Sarkozy, Vincent Camus, Stéphanie Guidez, Adrien Chauchet, Eric Deconinck, Krimo Bouabdallah, Franck Morschhauser, Roch Houot
Journal: Blood
Blood (2022) 140 (Supplement 1): 4639–4641.
https://doi.org/10.1182/blood-2022-162594
Published: 2022
Journal Articles

Nivolumab First-Line Therapy for Elderly, Frail Hodgkin Lymphoma Patients: Niviniho, a Lysa Phase II Study

Julien Lazarovici, Sandy Amorim, Krimo Bouabdallah, Stéphanie Guidez, Lysiane Molina, Franck Morschhauser, Anne-Claire Gac, Thomas Gastinne, Kamel Laribi, Vincent Launay, Bohrane Slama, Nawel Belmecheri, René-Olivier Casasnovas, Anne Corby, Eric Durot, Pierre Feugier, Emmanuelle Nicolas-Virelizier, David Sibon, Alina Berriolo-Riedinger, Veronique Edeline, Thierry Vander Borght, Diane Damotte, Alexandra Traverse-Glehen, Marc Andre, Vincent Ribrag
Journal: Blood
Blood (2021) 138 (Supplement 1): 232.
https://doi.org/10.1182/blood-2021-147863
Published: 2021
Journal Articles

Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Results of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"

Olivier Tournilhac, MD PhD, Maya Hacini, MD, Kamal Bouabdallah, MD, Kamel Laribi, MD, Marie Maerevoet, MD, Loic Ysebaert, MD PhD, Stephanie Guidez, Steven Le Gouill, MD PhD, Marc André, MD, Jehan Dupuis, MD, Catherine Thieblemont, MD PhD, Emmanuel Bachy, MD PhD, Nicolas Daguindau, MD, Franck Morschhauser, MD PhD, Sabine Tricot, MD, Pierre Feugier, MD PhD, Anne Banos, MD, Thierry Lamy De La Chapelle, MD PhD, Adrien Chauchet, MD, Emmanuel Gyan, MD PhD, Guillaume Cartron, MD PhD, Hassan Farhat, MD, Vincent Camus, Bernard Drenou, MD PhD, Hacene Zerazhi, MD, David Sibon, MD PhD, Emmanuelle Nicolas-Virelizier, MD, Caroline Delette, MD, Sylvia Snauwaert, MD, Nicole Straetmans, MD, Richard Delarue, MD, Marie Parrens, MD, Céline Bossard, MD, Laurence De Leval, MD, Philippe Gaulard, MD PhD, Gandhi Laurent Damaj, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-139224
Published: 2020
Journal Articles

Final Analysis of the Ro-CHOP Phase III Study (Conducted by LYSA): Romidepsin Plus CHOP in Patients with Peripheral T-Cell Lymphoma

Emmanuel Bachy, MD PhD, Vincent Camus, Catherine Thieblemont, MD PhD, Rene-Olivier Casasnovas, MD, Loic Ysebaert, MD PhD, Gandhi Laurent Damaj, MD PhD, Stephanie Guidez, Gian-Matteo Pica, MD, Won Seog Kim, MD PhD, Soon Thye Lim, MBBS, MRCP, FAMS, Marc André, MD, Alejandro Martin Garcia-Sancho, MD PhD, Maria Jesus Penarrubia Ponce, MD, Philipp B. Staber, MD PhD, Judith Trotman, FRACP, Andreas Hüttmann, MD, Vittorio Stefoni, MD PhD, Alessandro Re, MD, Philippe Gaulard, MD PhD, Marie-Helene Delfau-Larue, MD PhD, Laurence De Leval, MD, Michel Meignan, MD, Ju Li, PhD, Franck Morschhauser, MD PhD, Richard Delarue, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-134440
Published: 2020